课题基金 / 基金详情

ANTIHYPERTENSIVE ACTIVITY OF SR49059 IN HYPERTENSION IN TWO ETHNICITIES

ANTIHYPERTENSIVE ACTIVITY OF SR49059 IN HYPERTENSION IN TWO ETHNICITIES
SR49059 在两个种族高血压中的抗高血压活性
批准号:
5219150
负责人:
MARC THIBONNIER
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

MARC THIBONNIER的其他基金

相似基金

相关文献

中文摘要
翻译
本研究的目的是评估血压降低的效果
英文摘要
The objective of this study is to assess the blood pressure lowering effect of a single 300 mg oral dose of SR 49059 in African American and Caucasian hypertensive patients before, during, and after an hypertonic saline infusion. Based on pharmacology and both acute toxicology (LD0>2g/kg) and the 4-week repeated administration studies, and on preliminary safety data from the first single ascending oral dose tolerability trial, a minimal effective dose of 300 mg of SR 49059 is considered to be safe to be administered to humans. To date 6 subjects have completed the study. This is a single-dose, cross-over double blind study and all analyses will be carried out at the end of the study when the code is broken.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITU
  • 批准号:
    6191628
  • 项目类别:
  • 资助金额:
    $62.65万
  • 财政年份:
    1999
  • 负责人:
    MARC THIBONNIER
  • 依托单位:
PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITU
  • 批准号:
    6358398
  • 项目类别:
  • 资助金额:
    $183.32万
  • 财政年份:
    1999
  • 负责人:
    MARC THIBONNIER
  • 依托单位:
V1-VASCULAR VASOPRESSIN RECEPTORS OF MESANGIAL CELL
  • 批准号:
    6109948
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    1998
  • 负责人:
    MARC THIBONNIER
  • 依托单位:
VPA985 IN HYPONATREMIA DUE TO INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION
  • 批准号:
    6115286
  • 项目类别:
  • 资助金额:
    $1.92万
  • 财政年份:
    1998
  • 负责人:
    MARC THIBONNIER
  • 依托单位:
海外基金